CGON logo

CG Oncology (CGON) Company Overview

Profile

Full Name:

CG Oncology, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

Indexes:

Not included

Description:

CG Oncology focuses on developing innovative cancer therapies, particularly targeting bladder cancer. The company aims to improve treatment outcomes through its proprietary immunotherapy platform, enhancing the body’s immune response to fight cancer more effectively. Their research emphasizes advancing patient care and expanding treatment options in oncology.

Key Details

Price

$26.72

Annual Revenue

$204.00 K(+6.81% YoY)

Annual EPS

-$15.65(-33.65% YoY)

Annual ROE

-31.36%

Beta

1.44

Events Calendar

Earnings

Next earnings date:

Mar 14, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 13, 25 HC Wainwright & Co.
Buy
Jan 10, 25 HC Wainwright & Co.
Buy
Jan 7, 25 TD Cowen
Buy
Dec 6, 24 RBC Capital
Outperform
Dec 6, 24 HC Wainwright & Co.
Buy
Nov 13, 24 HC Wainwright & Co.
Buy
Nov 12, 24 HC Wainwright & Co.
Buy
Oct 24, 24 UBS
Buy
Oct 8, 24 B of A Securities
Buy
Sep 23, 24 RBC Capital
Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for CG Oncology?
  • Does CG Oncology pay dividends?
  • What sector is CG Oncology in?
  • What industry is CG Oncology in?
  • What country is CG Oncology based in?
  • Is CG Oncology in the S&P 500?
  • Is CG Oncology in the NASDAQ 100?
  • Is CG Oncology in the Dow Jones?
  • When was CG Oncology's last earnings report?
  • When does CG Oncology report earnings?
  • Should I buy CG Oncology stock now?

What is the ticker symbol for CG Oncology?

The ticker symbol for CG Oncology is NASDAQ:CGON

Does CG Oncology pay dividends?

No, CG Oncology does not pay dividends

What sector is CG Oncology in?

CG Oncology is in the Healthcare sector

What industry is CG Oncology in?

CG Oncology is in the Biotechnology industry

What country is CG Oncology based in?

CG Oncology is headquartered in United States

Is CG Oncology in the S&P 500?

No, CG Oncology is not included in the S&P 500 index

Is CG Oncology in the NASDAQ 100?

No, CG Oncology is not included in the NASDAQ 100 index

Is CG Oncology in the Dow Jones?

No, CG Oncology is not included in the Dow Jones index

When was CG Oncology's last earnings report?

CG Oncology's most recent earnings report was on Nov 12, 2024

When does CG Oncology report earnings?

The next expected earnings date for CG Oncology is Mar 14, 2025

Should I buy CG Oncology stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions